Export 8 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y [Z]   [Show ALL]
El-Darouti, M. A., S. A. Marzouk, O. Azzam, M. M. Fawzi, M. R. E. Abdel-Halim, A. A. Zayed, and T. M. Leheta, "Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis)", European Journal of Dermatology, vol. 16, no. 1, pp. 17–22, 2006. Abstract
Zayed, A. A., M. R. E. Abdel-Halim, K. S. Sayed, F. N. Mohammed, D. M. Hany, and K. S. Amr, "Transforming growth factor-$\beta$1 gene polymorphism in mycosis fungoides", Clinical and experimental dermatology, vol. 39, pp. 806–809, 2014. Abstract
El-Mofty, M., M. El-Darouti, H. RASHEED, D. A. Bassiouny, M. Abdel-Halim, N. S. Zaki, G. El-Hanafy, H. El-Hadidi, O. Azzam, A. El-Ramly, et al., "Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative", Journal of Dermatological Treatment, vol. 22, no. 1: Informa Healthcare USA on behalf of Informa UK Ltd. London, pp. 31–37, 2011. Abstract
El-Darouti, M. A., S. A. Marzouk, M. Bosseila, O. abu Zeid, O. El-Safouri, A. Zayed, A. El-Ramly, and M. R. E. Abdel-Halim, "Microscopic study of normal skin in cases of mycosis fungoides", International journal of dermatology, vol. 45, no. 9: Wiley Online Library, pp. 1043–1046, 2006. Abstract
El-Darouti, M. A., H. M. Mashaly, E. El-Nabarawy, A. M. Eissa, M. R. E. Abdel-Halim, M. M. T. Fawzi, N. H. El-Eishi, S. O. Tawfik, N. S. Zaki, A. Z. Zidan, et al., "Leukocytoclastic vasculitis and necrolytic acral erythema in patients with hepatitis C infection: Do viral load and viral genotype play a role?", Journal of the American Academy of Dermatology, vol. 63, no. 2: Elsevier, pp. 259–265, 2010. Abstract
Youssef, R., D. Mahgoub, O. A. Zeid, D. M. Abdel-Halim, M. El-Hawary, M. F. Hussein, M. A. Morcos, D. M. Aboelfadl, H. A. Abdelkader, Y. Abdel-Galeil, et al., "Hypopigmented Interface T-Cell Dyscrasia and Hypopigmented Mycosis Fungoides: A Comparative Study.", The American Journal of dermatopathology, vol. 40, issue 10, pp. 727-735, 2018 Oct. Abstract

Hypopigmented interface T-cell dyscrasia (HITCD) is a distinct form of lymphoid dyscrasia that may progress to hypopigmented mycosis fungoides (HMF). We compared both diseases as regards their CD4/CD8 phenotype and expression of granzyme B and tumor necrosis factor-alpha (TNF-α) and how these are affected by narrow-band UVB (nb-UVB). The study included 11 patients with HITCD and 9 patients with HMF. They received nb-UVB thrice weekly until complete repigmentation or a maximum of 48 sessions. Pretreatment and posttreatment biopsies were stained using anti CD4, CD8, TNF-α, and granzyme B monoclonal antibodies. Epidermal lymphocytes were CD8 predominant in 54.5% and 66.7% of HITCD and HMF cases, respectively, whereas dermal lymphocytes were CD4 predominant in 63.6% and 66.7%, respectively. Significantly, more dermal infiltrate was encountered in HMF (P = 0.041). In both diseases, granzyme B was only expressed in the dermis, whereas TNF-α was expressed both in the epidermis and dermis. No difference existed as regards the number of sessions needed to achieve repigmentation or cumulative nb-UVB dose reached at end of study. (P > 0.05). Narrow-band UVB significantly reduced only the epidermal lymphocytes in both diseases (P ≤ 0.05) with their complete disappearance in 8 (72.7%) HITCD and 6 (66.7%) HMF cases. In both diseases, nb-UVB did not affect granzyme B or TNF-α expression (P > 0.05). In conclusion, both diseases share the same phenotype, with HITCD being a milder form of T-cell dysfunction. In both diseases, epidermal lymphocytes are mainly CD8-exhausted cells lacking cytotoxicity, whereas dermal cells are mostly reactive cells exerting antitumor cytotoxicity. Tumor necrosis factor-alpha mediates hypopigmentation in both diseases and prevents disease progression. Repigmentation after nb-UVB in both diseases occurs before and independently from disappearance of the dermal infiltrate.

Zayed, A., M. Abdel-Halim, K. SAYED, and K. A. Faisal Nouredin, Doaa Hany, "Gene expression of FOXP3 and TGF-β1 in the blood of patients with mycosis fungoides, a hospital-based case–control study", EWDS, vol. 13, issue 3, pp. 133-136, 2016.
El-Darouti, M. A., S. A. Marzouk, M. R. E. Abdel-Halim, A. Z. Zidan, and M. M. Fawzy, "Basaloid follicular hamartoma", International journal of dermatology, vol. 44, no. 5: Wiley Online Library, pp. 361–365, 2005. Abstract